Skip to main content

Podcast

This weeks QD Clinics - Lessons from the clinic

QD209 - Recurrent Fevers; 3 Days at 103F https://youtu.be/whOxV89bKoQ QD210 - Double Positive, but Few Joints https://youtu.be/HxW012E4K2U QD211 Managing Septic Arthritis in RA https://youtu.be/K39sPOBTSII QD212 - I

NSAIDs In Pregnancy (3.3.2023)

Dr. Jack Cush reviews the lastest journal articles, news, and FDA announcements from the past week on RheumNow. This week, the importance of IFNa, Subclinical PsA and NSAID safety during Pregnancy.

QD Clinics - Lessons From The Clinic

QD205 - Chest Pain & Fever https://youtu.be/uw3V5NQTYTM QD206 - Arthralgia, Raynaud's & Anemia https://youtu.be/PUmQYDXayBc QD 207 - Molly's in trouble https://youtu.be/vIFTTqIxwsE QD 208 - VTE Options

The Late Edition (2.24.2023)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Half The Experts Are Wrong (2.17.2023)

Dr. Jack Cush reviews the news and tries to stump the expert panel this week on the podcast.

KNOW YOUR NUMBERS! (2.10.2023)

Dr. Jack Cush reviews the news, journal articles and the numbers, from the past week on RheumNow.com

Burnout #10 (2.2.2023)

Dr. Jack Cush reviews the past week of news on RheumNow.com

Simon Says “Don’t Do This” (1.27.2023)

Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything

The RheuNow Podcast Preview - Til Death Do Us Part (1.20.2023)

Dr. Jack Cush reviews the highlights from the past week on RheumNow.com

Rheum Believe It Or Not (1.13.2023)

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January. Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.

RheumNow Podcast- 2022 Rheumatology Year in Review

Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology Check out the full podcast at RheumNow.com

Fever, FROST, & Pericarditis (12.16.2022)

Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.
×